Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acer Therapeutics Inc
(NQ:
ACER
)
1.500
-0.020 (-1.32%)
Streaming Delayed Price
Updated: 1:18 PM EDT, Aug 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
33,907
Open
1.510
Bid (Size)
1.500 (2)
Ask (Size)
1.510 (6)
Prev. Close
1.520
Today's Range
1.500 - 1.550
52wk Range
1.163 - 3.770
Shares Outstanding
15,310,244
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
July 28, 2022
Via
Benzinga
FDA Accepts Acer's Inborn Metabolism Disorder Therapy Refiling For Review
July 28, 2022
The U.S. Food and Drug Administration (FDA) has accepted for review Acer Therapeutics’ (NASDAQ: ACER) resubmission of New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for oral suspension...
Via
Benzinga
Performance
YTD
-36.17%
-36.17%
1 Month
+3.45%
+3.45%
3 Month
-14.77%
-14.77%
6 Month
-35.90%
-35.90%
1 Year
-40.94%
-40.94%
More News
Read More
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Via
Benzinga
Acer Therapeutics: Q1 Earnings Insights
May 16, 2022
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Via
Benzinga
Here's Why Acer Therapeutics Shares Are Moving
July 08, 2022
Via
Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
July 08, 2022
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2022
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Via
Benzinga
FDA Rejects Acer Therapeutics - Relief Therapeutics' Urea Cycle Disorder Candidate
June 21, 2022
Via
Benzinga
Acer Therapeutics' Stock Down As FDA Rejects Inborn Metabolism Disorder (UCD) Candidate
June 21, 2022
Via
Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
June 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 06, 2022
Via
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May 31, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 17, 2022
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
May 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 16, 2022
Via
Benzinga
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
May 06, 2022
From
Relief Therapeutics Holdings AG
Via
AccessWire
Exposures
Product Safety
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
April 12, 2022
From
Relief Therapeutics Holdings AG
Via
AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 05, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 04, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.